Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046341 · ClinicalTrials.gov registry record · NA
Implementing Behavioral Sleep Intervention in Urban Primary Care
A NA study of Sleep and Sleep Disturbance, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04046341: Completed NA study of Sleep and Sleep Disturbance, sponsored by Children's Hospital of Philadelphia.
NCT04046341 is a NA study of Sleep and Sleep Disturbance that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 15 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04046341, a NA study of Sleep and Sleep Disturbance, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will enroll up to 20 participants from 3 Children's Hospital of Philadelphia (CHOP) primary care locations. The primary objective is to determine the whether the Sleep Well! behavioral sleep intervention is feasible to be implemented in primary care offices and acceptable to families. The direction and magnitude of change in child sleep from pre-intervention to post-intervention will also be examined.
Primary Outcome
The study team will track the number of caregiver-child dyad participants who complete all intervention procedures following enrollment.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Well!
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2020-07-03 |
| Phase | NA |
What the finished NCT04046341 record still lists
NCT04046341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Sleep Well! is the first listed.
NCT04046341 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04046341 about?
NCT04046341 is a clinical study titled "Implementing Behavioral Sleep Intervention in Urban Primary Care". Investigators will enroll up to 20 participants from 3 Children's Hospital of Philadelphia (CHOP) primary care locations. The primary objective is to determine the whether the Sleep Well! behavioral sleep intervention is feasible to be implemented in primary care offices and acceptable to families. ...
What is the current status of trial NCT04046341?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-10-14. Estimated completion is 2020-07-03.
What conditions does trial NCT04046341 study?
This clinical trial studies the following conditions: Sleep, Sleep Disturbance, Sleep Deprivation.
What interventions are being tested in trial NCT04046341?
The interventions under investigation include: Sleep Well! (BEHAVIORAL).
Who is sponsoring clinical trial NCT04046341?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04046341 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04046341's enrollment target sits among peer trials
15 143rd of 151 higher than 8 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI